Abiopharma

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE)

Symbol	ARE
Name	ALEXANDRIA REAL ESTATE EQUITIES, INC.
Sector	REAL ESTATE
Region	North America
Industry	Real Estate Investment Trusts
Address	26 NORTH EUCLID AVENUE, PASADENA, CA 91101
Telephone	6265780777
Fax	—
Email	—
Website	https://www.are.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001035443
Description	Alexandria Real Estate Equities Inc is a real estate investment trust primarily engaged in the acquisition, development, and leasing of urban offices on science and technology campuses throughout the United States. The company redevelops offices, warehouses, and shell space for its tenants in areas close to high concentrations of specialized research institutions and businesses. The majority of Alexandrias real estate portfolio is split between the Greater Boston and San Francisco areas. The company derives nearly all of its income in the form of revenue from its tenant companies. Alexandrias largest customers in terms of revenue are public biotechnology, multinational pharmaceutical, life science product, and academic and medical research entities. Additional info from NASDAQ: Alexandria Real Estate Equities Inc is a real estate investment trust primarily engaged in the acquisition, development, and leasing of urban offices on science and technology campuses throughout the United States. The company redevelops offices, warehouses, and shell space for its tenants in areas close to high concentrations of specialized research institutions and businesses. The majority of Alexandrias real estate portfolio is split between the Greater Boston and San Francisco areas. The company derives nearly all of its income in the form of revenue from its tenant companies. Alexandrias largest customers in terms of revenue are public biotechnology, multinational pharmaceutical, life science product, and academic and medical research entities.

2026-09-04 12:30

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

2026-09-02 20:16

Moglia Peter M 🔴 sold 1.1K shares of ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) at $51.29 Transaction Date: Aug 31, 2026 | Filing ID: 000026

2026-09-02 20:13

Gavinet Andres 🔴 sold 10.0K shares of ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) at $50.93 Transaction Date: Aug 31, 2026 | Filing ID: 000009

2026-09-01 12:30

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 3Q26

2026-08-31 15:57

📋 Gavinet Andres (Officer) plans to sell 10K shares of ALEXANDRIA REAL ESTATE EQUITIES, INC. (at $50.93 each, total $509K) Filed: Aug 31, 2026 | ID: 006542

2026-08-27 15:11

Aecon joint venture executes alliance contracts to advance GO Expansion rail transit project in Ontario

2026-08-25 12:30

Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2026 Operating and Financial Results Conference Call and Webcast on October 27, 2026

2026-08-21 20:30

(99% Neutral) ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) Announces Business Combination

2026-08-19 20:37

Director MARCUS JOEL S 🟢 acquired 5.0K shares of ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) at $46.28 Transaction Date: Aug 17, 2026 | Filing ID: 000019

2026-08-14 18:02

New Form 424B5 - ALEXANDRIA REAL ESTATE EQUITIES, INC. Filed: 2026-08-14 AccNo: 0001104659-26-097328 Size: 1 MB